ELITech provides innovative products and solutions to serve laboratories operating closer to the patient. The Group offers clinical chemistry, microbiology, molecular diagnostics and immunology.
PSS and ELITech Group enter into a Joint Development, Distribution and Supply Agreement on PSS’s “geneLEAD”, a fully automated, sample-to-result, Real-Time PCR analyzer.
We are proud to announce that we are changing the company name of our French Manufacturing Unit from SEPPIM to ELITech Clinical Systems SAS (France) starting on January 10th, 2013.
Paris, January 2, 2013 – ELITech Group (“ELITech”) announces today the acquisition of 100% of the share capital of Vital Diagnostics Holding Corp. (“Vital Diagnostics”) from New River Management IV, LP and Third Security Staff 2001, LLC, both affiliates of Third Security, LLC, a US-based venture capital firm, and TeeTwo Nominees Pty Ltd.
International Working Group and Industry Leaders propose nomenclature recommendation for the unique methicillin-resistant S. aureus variant, mecALGA251
EXCLUSIVE: ELITech Molecular Diagnostics launches SECOND GENERATION Real-Time PCR MRSA Kit that detects the mecALGA251 gene.
ELITech Molecular Diagnostics receives FDA clearance for commercial Real-Time PCR MRSA/SA test.